Clinical Trial Update: 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating 18F-fluciclovine PET imaging for brain metastases treated with stereotactic radiosurgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Axumin (fluciclovine F-18) (fluciclovine F-18)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Brain Metastases, Brain Metastases, Adult | Phase 1 | Status: RECRUITING